SCHEMBL26045769

SCHEMBL26045769

CCn1c(C(O)(c2ccccc2)c2ccccc2)nc2cc(OC)c(C(=O)Nc3nc[nH]n3)cc21

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACSS2 Q9NR19 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26044492 0.86 ACSS2 (0.59) ACSS2
SCHEMBL26044490 0.82 ACSS2 (0.64) ACSS2
SCHEMBL23843521 0.82 ACSS2 (0.46) ACSS2
SCHEMBL23843428 0.78 ACSS2 (0.68) ACSS2
SCHEMBL17267033 0.74 ACSS2 (0.63) ACSS2
SCHEMBL17263225 0.72 ACSS2 (1.00) ACSS2
SCHEMBL18674941 0.71 ACSS2 (1.00) ACSS2
SCHEMBL18674942 0.71 ACSS2 (0.78) ACSS2
SCHEMBL17263204 0.71 ACSS2 (1.00) ACSS2
SCHEMBL23832298 0.71 ACSS2 (0.80) ACSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271956-A1 AMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271956-A1 AMIDE DERIVATIVES BRCA1, HRAS, PCNA ACSS2 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback